DIAG723 for pulmonary arterial hypertension

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Jun 2026: Trial registered, NCT07623525
  2. 4 Jun 2026: Trial started, NCT07623525

The trials

NCT07623525: DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia

State
Under way
Phase
Phase 1 and Phase 2
People
93 planned
Started
4 Jun 2026
Primary completion
30 Nov 2027
Arms
DIAG723
Results
None posted
  1. 3 Jun 2026: Trial registered
  2. 4 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.